Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
39 EUR | +1.04% | 0.00% | 0.00% |
06-13 | Xilio Therapeutics, Inc. Announces Board Appointments | CI |
06-06 | UL Solutions and ScienceMedia Partner to Revolutionize Training and E-Learning Solutions for Life Sciences | CI |
Sales 2024 * | 2.81B 2.62B 3.84B | Sales 2025 * | 2.95B 2.76B 4.04B | Capitalization | 8.37B 7.83B 11.46B |
---|---|---|---|---|---|
Net income 2024 * | 282M 264M 386M | Net income 2025 * | 293M 274M 401M | EV / Sales 2024 * | 3.18 x |
Net Debt 2024 * | 543M 508M 743M | Net Debt 2025 * | 392M 366M 536M | EV / Sales 2025 * | 2.97 x |
P/E ratio 2024 * |
29.9
x | P/E ratio 2025 * |
28.6
x | Employees | - |
Yield 2024 * |
1.19% | Yield 2025 * |
1.26% | Free-Float | 19.4% |
Current month | +9.55% | ||
1 month | +12.55% |
Date | Price | Change |
---|---|---|
24-06-21 | 39 | +1.04% |
24-06-20 | 38.6 | +0.52% |
24-06-19 | 38.4 | 0.00% |
24-06-18 | 38.4 | -0.52% |
24-06-17 | 38.6 | -1.03% |
Real-time BOERSE MUENCHEN, June 21, 2024 at 03:44 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.38% | 2.51B | |
-19.17% | 2.46B | |
-21.48% | 1.98B | |
-11.11% | 1.02B | |
-17.85% | 977M | |
+5.10% | 870M | |
-4.56% | 723M | |
-25.60% | 692M | |
+6.99% | 584M |
- Stock Market
- Equities
- ULS Stock
- 72R Stock